Bayer AG, a leading global pharmaceutical and biotechnology company, and TetraScience, the Scientific Data and AI Cloud company, announced an agreement aimed at maximizing the value of scientific data and driving innovation. This collaboration will support Bayer’s mission to deliver the next generation of life-changing therapeutics and ensure global food security.
“We are excited to partner with TetraScience on our digital transformation journey and to drive innovation”
Through the use of the Tetra Scientific Data and AI Cloud™, Bayer teams across various divisions, including cell and gene therapy, biopharma, and crop sciences, will be able to collect, centralize, and transform scientific data into a liquid, vendor-agnostic format. This format will be readily accessible for lab informatics, data science, and AI applications, enabling researchers to unlock valuable insights with the potential to accelerate the development of products.
Recommended AI News: GSMA and IBM Collaborate to Accelerate AI Adoption and Skills for the Telecoms Sector
“We are excited to partner with TetraScience on our digital transformation journey and to drive innovation,” says Oliver Hesse, Bayer’s Vice President and Head of Biotech Data Science and Digitalization. “By maximizing the value of our scientific data and leveraging advanced data management and data science solutions, we can unlock new insights and opportunities for breakthrough innovations. This collaboration with TetraScience is an integral part of our broader digital transformation strategy, enabling us to enhance our R&D capabilities.”
As Bayer continues its digital innovation efforts across multiple divisions, collaboration among laboratories, scientific groups, informatics technologies, and divisions becomes crucial. By adopting a cloud-based data platform provided by TetraScience, scientists will have the ability to easily access and relate data to experimental context, as well as share data seamlessly between teams in both regulated and non-regulated environments.
Recommended AI News: Korea Quantum Computing and IBM Collaborate to Bring IBM watsonx and Quantum Computing to Korea
“We are proud to have Bayer as a partner,” says Patrick Grady, Chairman and CEO of TetraScience. “Together, we will continue to push the boundaries of discovery by maximizing the value of scientific data and opening the path to AI. Supporting Bayer’s relentless focus on unrestricted scientific innovation with the Tetra Scientific Data and AI Cloud will help solve some of the greatest human challenges.”
Recommended AI News: RingCentral Revolutionizes Patient Care Communications with EHR Integrations and Generative AI
[To share your insights with us as part of editorial or sponsored content, please write to sghosh@martechseries.com]
Comments are closed.